Nutritional problems of patients infected with COVID-19 and potential for nutritional management of disorders

Introduction. One of the most significant issues that require close attention in the treatment and rehabilitation of patients with coronovirus infection is the analysis of the nutritional status of patients and the development of approaches to nutritional support for patients.

Aim of study. Analysis of nutritional status of patients infected with COVID-19 and studying the effectiveness of specialized products dietary therapeutic and preventive nutrition during illness and recovery period.

Materials and methods. A survey of 283 patients with mild and moderate severity was conducted. The survey showed a significant change in eating behavior in patients during the disease. To assess the effectiveness of nutritional support during the disease and during the recovery period, 36 individuals took a specialized product of dietary therapeutic and preventive nutrition “Detoxifying Kissel” LEOVIT DETOX daily after the diagnosis of COVID-19, both throughout the entire period of the disease, and within 2 weeks after the disease and going to work.

Results and discussion. The survey showed the presence of a significant range of eating disorders in patients with coronavirus disease. It was found that in 90% of the respondents during the day, the main meal was 3 or more times. During the disease, the number of main meals decreased in 40% of individuals, and only in 4% of patients this figure increased. When using nutritional support with dietary therapeutic and prophylactic foods during the disease, patients noted a significant decrease in weakness and fatigue, temperature fluctuations, fears, anxiety, suspiciousness and other symptoms began to disappear. The continuation of the intake in the post-ovoid period of the use of nutritional support with the dietary therapeutic and preventive food product “Detoxifying Kissel” LEOVIT DETOX, contributes to a faster recovery of patients.

Conclusion. The use of the dietary therapeutic and preventive food product “Detoxifying Kissel” LEOVIT DETOX is an effective method of nutritional support both during the disease and in the post-ovoid period. Long-term use of detoxification products (at least 3–6 months) after the disease is recommended.

1. Filippo L., Lorenzo R., D’Amico M., Sofia V., Roveri L., Mele R. et al. COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study. Сlin Nutr. 2020;S0261-5614(20):30589-30596. doi: 10.1016/j.clnu.2020.10.043.

2. Barazzoni R., Bischoff S. C., Breda J., Wickramasinghe K., Krznaric Z., Nitzan D. et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631–1638. doi: 10.1016/j.clnu.2020.03.022.

3. Sanson G., Bertocchi L., Dal Bo E., Di Pasquale C. L., Zanetti M. Identifying reliable predictors of protein-energy malnutrition in hospitalized frail older adults: A prospective longitudinal study. Int J Nurs Stud. 2018;82:40–48. doi: 10.1016/j.ijnurstu.2018.03.007.

4. Hunter J. V., Goerner L. Infections. Handb Clin Neurol. 2016;136:1173–1198. doi: 10.1016/B978-0-444-53486-6.00061-2.

5. De Riccardis L., Buccolieri A., Muci M., Pitotti E., De Robertis F., Trianni G. et al. Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects. Biochim Biophys Acta. 2018;1864(5 Pt A):1828–1838. doi: 10.1016/j.bbadis.2018.03.007.

6. Chaturvedi U. C., Shrivastava R., Upreti R. K. Viral infections and trace elements: a complex interaction. Cur Sci. 2004;87(10):1536–1554. Available at: https://www.currentscience.ac.in/cs/Downloads/article_id_087_11_1536_1554_0.pdf.

7. Chaturvedi U. C., Shrivastava R., Upreti R. K. Viral infections and trace elements: a complex interaction. Cur Sci. 2004;87(10):1536–1554. Available at: https://currentscience.ac.in/cs/Downloads/article_id_087_11_1536_1554_0.pdf.

8. Prasitlumkum N., Chokesuwattanaskul R., Thongprayoon C., Bathini T., Vallabhajosyula S., Cheungpasitporn W. Incidence of myocardial injury in COVID-19-infected patients: a systematic review and meta-analysis. Diseases. 2020;8(4):40. doi: 10.3390/diseases8040040.

9. Inciardi R. M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819–824. doi: 10.1001/jamacardio.2020.1096.

10. Singh S., Desai R., Gandhi Z., Fong H. K., Doreswamy S., Desai V. et al. Takotsubo syndrome in patients with COVID-19: a systematic review of published cases. SN Compr Clin Med. 2020;2:2102–2108. doi: 10.1007/s42399-020-00557-w.

11. Zeng J. H., Liu Y. X., Yuan J., Wang F. X., Wu W. B., Li J. X. et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48(5):773–777. doi: 10.1007/s15010-020-01424-5.

12. McNeary L., Maltser S., Verduzco-Gutierrez M. Navigating coronavirus disease 2019 (COVID-19) in physiatry: a CAN report for inpatient rehabilitation facilities. PM R. 2020;12(5):512–515. doi: 10.1002/pmrj.12369.

13. Chang M. C., Park D. How should rehabilitative departments of hospitals prepare for coronavirus disease 2019? Am J Phys Med Rehabil. 2020;99(6):475–476. doi: 10.1097/PHM.0000000000001428.

14. Jiménez D., García-Sanchez A., Rali P., Muriel A., Bikdeli B., Ruiz-Artacho P. et al. Incidence of venous thromboembolism and bleeding among hospitalized patients with COVID-19: a systematic review and meta-analysis. Chest. 2020;159(3):1182–1196. doi: 10.1016/j.chest.2020.11.005.

15. Kunutsor S. K., Laukkanen J. A. Hepatic manifestations and complications of COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(3):72–74. doi: 10.1016/j.jinf.2020.06.043.

16. Afanaseva A. N. . Comparative assessment of the endogenous intoxication level in persons of different ages. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics. 2004;(6):11–13. (In Russ.).

17. Vitkina T. I. Middle molecular bstances in assessing the level of endogenous ation chronic nonobstructive bronchitis. Zdorov’e. Meditsinskaya ekologiya. Nauka = Health. Medical ecology. Science. 2014;(56):70–72. (In Russ.) Available at: http://hmes-jornal.narod.ru/HMES56-2014/hmes_56-2014-art-24-.pdf.

18. Lodyagin A. N., Batotsyrenov B. V., Shikalova I. A., Voznyuk I. A. Acidosis and toxic hemolysis – goals of path genetic treatment of polyorgan pathology in COVID-19. Vestnik vosstanovitel’noy meditsiny = Bulletin of Rehabilitation Medicine. 2020;97(3):25–30. (In Russ.) doi: 10.38025/2078-1962-2020-97-3-25-30.

19. Luzhnikova E. A. (ed.). Medical toxicology: national guidelines. Moscow: GEOTARMedia; 2014. 928 p. (In Russ.) Available at: https://docplayer.ru/51854183-Medicinskaya-toksikologiya.html.

20. Savcheno R. P. Influence of oxidative “stress” on the platelet functional activity in patients with renal pathology. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics. 2005;(10):72. (In Russ.)

21. Kotenko K. V. (ed.). Emergency medical care for poisoning. Moscow: Praktika; 2010. 1440 p. (In Russ.).

22. Arnold D. T., Hamilton F. W., Milne A., Morley A. J., Viner J., Attwood M. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020;76(4):399–401. doi: 10.1136/thoraxjnl-2020-216086.

23. Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H. et al. Postdischarge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6. doi: 10.1016/j.jinf.2020.08.029.

24. Ran L., Zhao W., Wang J., Wang H., Zhao Y., Tseng Y., Bu H. Extra Dose of Vitamin C Based on aDaily Supplementation Shortens the Common Cold: A Meta-Analysis of 9 Randomized Controlled Trials. Biomed Res Int. 2018;2018:1837634. doi: 10.1155/2018/1837634.

25. Yang F., Zhang Y., Tariq A., Jiang X., Ahmed Z., Zhihao Z. et al. Food as medicine: A possible preventive measure against coronavirus disease (COVID-19). Phytother Res. 2020;34(12):3124–3136. doi: 10.1002/ptr.6770.

26. Shivappa N., Steck S. E., Hurley T. G., Hussey J. R., Hebert J. R. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–1696. doi: 10.1017/S1368980013002115.

27. O’Keefe J. H., Gheewala N. M., O’Keefe J. O. Dietary strategies for improving postprandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol. 2008;51(3):249–255. doi: 10.1016/j.jacc.2007.10.016.

28. Osman A. Protein Energy Malnutrition and Susceptibility to Viral Infections as Zika and Influenza Viruses. J Nutr Food Sci. 2016;6:3. doi: 10.4172/2155-9600.1000489.

29. Arora S. K., McFarlane S. I. The case for low carbohydrate diets in diabetes management. Nutr Metab (Lond). 2005;2:16. doi: 10.1186/1743-7075-2-16.

30. King D. E., Egan B. M., Woolson R. F., Mainous A. G. 3rd, Al-Solaiman Y., Jesri A. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007;167(5):502–506. doi: 10.1001/archinte.167.5.502.

31. Poudel-Tandukar K., Chandyo R. K. Dietary B Vitamins and Serum C-Reactive Protein in Persons With Human Immunodeficiency Virus Infection: The Positive Living With HIV (POLH) Study. Food Nutr Bull. 2016;37(4):517–528. doi: 10.1177/0379572116657268.

32. Ma Y., Griffith J. A., Chasan-Taber L., Olendzki B. C., Jackson E., Stanek E. J. III et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr. 2006;83(4):760–766. doi: 10.1093/ajcn/83.4.760.

33. Van Herpen-Broekmans W. M. R., Klopping-Ketelaars I. A. A., Bots M. L., Kluft C., Princen H., Hendriks H. F. J. et al. Serum carotenoids and vitamins in relation to markers of endothelial function and inflamation. Eur J Epidemiol. 2004;19(10): 915–921. Available at: https://www.jstor.org/stable/3582671?seq=1.

34. Upritchard J. E., Sutherland W. H., Mann J. I. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 2000;23(6):733–738. doi: 10.2337/diacare.23.6.733.

35. Devaraj S., Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med. 2000;2(8):790–792. doi: 10.1016/s0891-5849(00)00420-2.

36. Murphy R. T., Foley J. B., Tome M. T., Mulvihill N. T., Murphy A., McCarroll N. et al. Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes. Free Radic Biol Med. 2004;36(8):959–965. doi: 10.1016/j.freeradbiomed.2004.01.018.

37. Erlinger T. P., Guallar E., Miller E. R. 3rd, Stolzenberg Solomon R., Appel L. J. Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch Intern Med. 2001;161(15):1903–1908. doi: 10.1001/archinte.161.15.1903.

38. Kritchevsky S. B., Bush A. J., Pahor M., Gross M. D. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol. 2000;152(11):1065–1071. doi: 10.1093/aje/152.11.1065.

39. Khan N., Khymenets O., Urpi-Sarda M., Tulipani S., Garcia-Aloy M., Monagas M. et al. Cocoa polyphenols and inflammatory markers of cardiovascular disease. Nutrients. 2014;6(2):844–880. doi: 10.3390/nu6020844.

40. King D. E., Egan B. M., Geesey M. E. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol. 2003;92(11):1335–1339. doi: 10.1016/j.amjcard.2003.08.020.

41. Esmaillzadeh A., Kimiagar M., Mehrabi Y., Azadbakht L., Hu F. B., Willett W. C. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr. 2007;137(4):992–998. doi: 10.1093/jn/137.4.992.

42. Aeberli I., Gerber P. A., Hochuli M., Kohler S., Haile S. R., Gouni-Berthold I. et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: A randomized controlled trial. Am J Clin Nutr. 2011;94(2):479–485. doi: 10.3945/ajcn.111.013540.

43. Chrysohoou C., Panagiotakos D. B., Pitsavos C., Das U. N., Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol. 2004;44(1):152–158. doi: 10.1016/j.jacc.2004.03.039.

44. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular nflammation in the metabolic syndrome: A randomized trial. JAMA. 2004;292(12):1440–1446. doi: 10.1001/jama.292.12.1440.

45. Estruch R., Martinez-Gonzalez M. A., Corella D., Salas-Salvadó J., Ruiz-Gutiérrez V., Covas M. I. et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: A randomized trial. Ann Intern Med. 2006;145(1):1–11. doi: 10.7326/0003-4819-145-1-200607040-00004.

46. Serrano-Martinez M., Palacios M., Martinez-Losa E., Lezaun R., Maravi C., Prado M. et al. A Mediterranean dietary style influences TNF-alpha and VCAM-1 coronary blood levels in unstable angina patients. Eur J Nutr. 2005;44(6):348–354. doi: 10.1007/s00394-004-0532-9.

47. Pilat T. L., Kuz’mina L. P., Izmerova N. I. Detox diet. Moscow: GEOTAR-Media; 2012. 688 p. (In Russ.) Available at: https://www.rosmedlib.ru/book/ISBN9785970421451.html.

48. Pilat T. L., Bezrukavnikova L. M., Kolyaskina M. M., Bessonov V. V., Anvarul N. A., Khanferyan R. A. Study of effectiveness of detoxing impact of the complex detox nutrition program on functional parameters of the organism. Terapiya = Therapy. 2020;(2):156–163. (In Russ.) doi: 10.18565/therapy.2020.2.156-163.